
Higher-dose naloxone spray doesn't increase overdose survival, study finds
Fox News
A study compared a new, stronger nasal spray for opioid overdoses with the standard dose. Despite being twice as potent, it didn't save more lives and caused more side effects.
The new study, which was limited to more rural parts of New York state, is being called the first to provide real-world data on the differences between the two sprays. The paper was published by the Centers for Disease Control and Prevention, but the federal health agency was not involved in the research.
More Related News













